Scientists at the University of Liverpool have, for the first time, revealed that digital dermatitis (DD) has been present on hoof knifes used on cattle and sheep following research1 jointly funded by DairyCo and EBLEX.
The research conducted at the University investigated if DD Treponeme can be present on equipment used to trim cattle and sheep hooves. The research team, led by Dr Nicholas Evans and Professor Stuart Carter of the University of Liverpool and in collaboration with Roger Blowey MRCVS, tested trimming equipment used on cattle and sheep with digital dermatitis and after it was disinfected.
After trimming, DD was present on 97% of cattle blades and 100% of sheep blades. This was reduced to 29% and 46% respectively after disinfection.
Dr Evans said: "It has long been considered that digital dermatitis was spread in slurry which we have some evidence for and are continuing to investigate but now, for the first time, we have discovered the digital dermatitis bugs in the farm environment.
"However, the high detection rate of digital dermatitis bacteria on trimming blades soon after trimming cattle and sheep hooves from digital dermatitis cases suggests this may be a significant and worrying route for the transmission of this infectious condition."
Leigh Sullivan, who conducted the field work as part of her study, said: "Interestingly, in the world of human dentistry, a completely different species of the bacteria is found to cause gum disease. Furthermore, studies have shown it will adhere to metal on orthodontic braces which is consistent with our detection of the digital dermatitis Treponeme on metallic trimming knives."
Dr Jenny Gibbons, DairyCo research & development manager, added: "This DairyCo and EBLEX-funded study could help farmers, vets and hoof trimmers to understand more about the transmission of digital dermatitis between cows and farms. A logical precaution to limit the spread is to disinfect hoof trimming equipment between animals and between farms."
To find out more about this and other R&D projects, DairyCo is hosting a research day on 17 July at Trenault Farm, Launceston, Cornwall.
To book a place, visit: dairyco.org.uk/researchday2014
Reference
The session will provide a practical guide to dealing with various emergencies that may present to vets and nurses across multiple disciplines.
The full schedule includes:
Arlene Connor, Interim Hospital Director at Hamilton Specialist Referrals, said: “Being presented with an emergency patient can be an intense and high-pressure situation, and it’s one that all vet professionals should do their best to prepare for so they are comfortable making decisions under pressure.
"We have a brilliant team here at Hamilton Specialist Referrals, all of whom are well equipped and very experienced when it comes to dealing with emergencies and this is an unrivalled opportunity to learn from them.”
Tickets cost £80+vat, including lunch and refreshments
https://www.eventbrite.co.uk/e/the-emergency-patient-tickets-861637851007
www.hamiltonspecialists.vet
Virbac has announced a special promotion in which practices can earn a specialist ear instrument kit worth £100
The kit, which has been designed by Virbac vets in consultation with a number of veterinary dermatologists, is available with multiple purchases of the otitis treatment EasOtic, and the neutral pH glycotechnology ear cleaner Epi-Otic.
Product manager Chris Geddes MRCVS said: "Each kit contains a haemostat, ear forceps, 3 various cerumen scoops and a Spreulls ear-flushing needle. Basically it's the best ear equipment for daily use by practitioners. For a limited period we are giving away one set FOC with every purchase of 25 bottles of EasOtic and 25 bottles of Epi-Otic."
Chris added: "When it comes to treatment of otitis, we know that client compliance is a key issue. The award-winning design of EasOtic makes it an extremely easy product to use. The 'one pump' delivery system helps deliver more accurate dosing and minimises animal stress during application. This means that treatment courses are more likely to be completed, thus optimising results and client satisfaction all round."
For further information, please contact your local Virbac territory manager or call Virbac on 01359 243243.
The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.
The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.
It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse.
The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.
Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.
Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.
Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.
"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”
To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.
UK veterinary surgeons strongly prefer recommending branded treatments, according to a survey conducted by specialist advertising agency Masius.
The survey, conducted amongst members of www.vetsurgeon.org, received 725 responses. It gave a conclusive insight to veterinary surgeons' opinions on branding, with 87% of respondents saying that they prefer to recommend a branded POM-V over a generic equivalent.
While branded treatments are clearly preferred over generics, vets recognise that higher prices can be an issue for clients. Price is justified mainly through a higher level of trust in the quality of the product (through extensive trialling). They also cite the added support in the event of client usage issues and the value that clients attach to brands. The cascade is a further factor, requiring the use of licensed drugs.
When it comes to supplements, vets are still in favour of brands, but less so - as the cascade is not a factor. On the issue of price differential, most vets felt that a premium of 10-25% is justifiable for a brand over a generic.
Jonathan Posner, Business Director at Masius said: "As well as the quantitative data, we also got some interesting qualitative comments as well. Looking at these, one can see a range of opinions - from the vets who value the easier client acceptance of brands, to those who feel that their professional care of the patient is paramount and that a generic should be used where it delivers the same benefit as a brand. Client ability to pay was also mentioned as a factor - a generic being more likely to lead to compliance for a client on a tight budget."
The fact that branded products come with better information and marketing support was agreed by the large majority (93%) of respondents.
All the participants in the survey were entered into a draw to win an iPad 2. The winner of the draw was Megan Wood MRCVS (pictured right) from Fife. She said: "The iPad is brilliant; I love it, and am a lucky lady!"
The RCVS and BVA have expressed their concern about a BBC Newsline report last week of suspected badger baiting in Northern Ireland, which also alleged that veterinary surgeons might be complicit in this illegal activity by not reporting cases of suspiciously injured animals to the relevant authorities.
Bert Allison MRCVS, President of the North of Ireland Veterinary Association, said: "Our Association, and veterinary surgeons across Northern Ireland and Great Britain, are sickened and appalled by these activities. We are grateful to the BBC for highlighting the problem and bringing it to the attention of the public.
"Veterinary surgeons work under a professional code of conduct to uphold animal health and welfare and care deeply about the animals under their care. The claim by USPCA that veterinary surgeons are deliberately failing to report incidents is therefore shocking.
"However, if there is evidence that this has happened the USPCA must provide all relevant information to the Royal College of Veterinary Surgeons which is the statutory regulator of the veterinary profession.
"Under our professional code all veterinary surgeons must provide treatment to alleviate the suffering of an animal presented to them however the gangs abusing these animals may be obtaining veterinary care by deception. We are contacting our members urgently to offer support and remind them how to report suspected incidents safely and within the law."
The RCVS says it has yet to be presented with any evidence to support the claims, but will investigate any genuine complaint supported by first-hand evidence.
The College is also reminding veterinary surgeons about its guidance concerning breaching client confidentiality where a veterinary surgeon believes that animal welfare or the public interest may be compromised.
If there is suspicion of animal abuse, as a result of examining an animal, a veterinary surgeon should consider whether the circumstances are sufficiently serious to justify breaching the usual obligations of client confidentiality.
In cases where discussing these concerns with the client would not be appropriate, or where the client's reaction increases rather than allays these concerns, the veterinary surgeon should contact the relevant authorities, for example the RSPCA, SSPCA or USPCA, to report alleged cruelty to an animal.
Such action should only be taken when the veterinary surgeon considers on reasonable grounds that the public interest in protecting an animal overrides the professional obligation to maintain client confidentiality.
A veterinary surgeon may contact the RCVS for advice before any confidential information is divulged (020 7202 0789 / profcon@rcvs.org.uk).
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
The company's charity of the year is chosen by employees at its annual conference in October. Fundraising then begins the following January.
This year, fundraising activities included cake sales, 'wearing blue days' and dog shows. Others took a more energetic approach: a team from Tone Veterinary Centre in Taunton cycled the equivalent of Land’s End to John O’Groats on exercise bikes over a fortnight, raising £525, while groomer Ceri James from Petherton Vets in Cardiff climbed Ben Nevis.
Simon Innes, CVS Chief Executive said: "Each year, thousands of cats, dogs, small animals and horses rely on the hospitals, clinics and rehoming services run by Blue Cross so it was a very natural charity for us to support and the overwhelming winner of last year’s vote.
"Yet again, our teams have surpassed themselves by really getting behind our fundraising efforts and showing great creativity and dedication to the task. Judging by some of the photos, they also seem to have had a great deal of fun. We held a group-wide charity day during July in which all parts of the business participated. It was a fantastic event and really showed the power of collective fundraising."
Matt Cull, Deputy Director of Fundraising at Blue Cross, said: "The dedication from CVS to fundraise for our pets through many different activities is so inspiring. We are very grateful to all the teams for helping Blue Cross as the money raised will assist us in helping thousands of pets in need and support our other charitable activities, such as our education programmes and bereavement support service. Pets change lives and with this generous help, we can change theirs."
Photo: Simon Innes CVS Group Chief Executive; Diane James, Blue Cross; Piers Gibbon, CVS Conference compere
Virbac is running a promotion through which practices can claim a model showing the anatomy of a healthy dog ear canal on one side, and the changes associated with chronic damage on the other.
Product Manager Chris Geddes MRCVS said: "The models are about 15cm high and provide a useful visual aid to show clients the consequences if chronic ear disease is not kept under control. They can also be used to help show clients how to administer their pet's treatment correctly.
"These models will be a useful tool for practices to help improve client compliance. Also, we know that some dog owners find a course of ear treatments tricky, and either give the wrong dose or give up altogether, which is why we designed EasOtic to dispense the exact dose in one simple 'squirt', with one complete course in each bottle".
For details of how you can obtain a model for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
Eggshell membrane is rich in proteins and contains collagen type I, hyaluronic acid, chondroitin sulphate and glucosamine. Virbac says the components of eggshell membrane help to limit inflammatory processes that occur in osteoarthritis and preserve the existing cartilage structure whilst promoting synthesis. The company points to a study which showed that eggshell membrane contributes to a reduction in pain perception by 25%, improved joint function by 33% and increased quality of life by 35% within 6 weeks1.
Rémi Mandray, Product Manager at Virbac said: "I am delighted to be able to introduce this innovative new ingredient to the Veterinary HPM Joint & Mobility Clinical Diet. This is an addition to an already very comprehensive approach to nutrition in dogs with osteoarthritis, which affects 20% of the adult canine population2. Studies have shown that improvement on mobility is visible as quickly as 2 weeks after diet introduction3 – changing their diet truly can change their life!’
For more information contact your Virbac Territory Manager.
Purina says the foods contain adjusted and graded levels of protein and phosphorus to address the delicate balance of providing needed protein in older cats against uraemic toxin production in late phase renal decline.
The current advice is that phosphate should be restricted when the renal patient has confirmed CKD, and IRIS provides therapeutic serum phosphate targets for each stage.
Dr Ellie Groves BA(Hons) VetMB MRCVS, Purina Technical Manager for the UK and Ireland, said: “As obligate carnivores, cats have a high requirement for protein, however, around 20% of senior cats have decreased ability to digest protein, and so are absorbing less protein.
"An inadequate intake of protein leads to loss of lean body mass as muscle is catabolised to meet this need.
"We know that this loss of lean body mass is significantly correlated with an increased risk of mortality.
"But we need to be careful – in renal disease, there is the potential for protein breakdown products to increase in the circulation, acting as toxins.
"So, we need to fine-tune the amount of protein, depending on the stage of chronic renal insufficiency (CRI).
"A dual approach, with Early and Advanced products, allows tailoring of protein levels.”
“Alongside protein, phosphorus content is also tailored to the stage of kidney decline.
"Restricting phosphorus can slow the progression of chronic kidney disease by reducing morphological damage to the kidneys and is thought to be the most important influencer of survival in cats with CKD.
"The levels of phosphorus in the products, are tailored, alongside the protein, to reflect the needs of the cat, with increased restriction when cats are in advanced decline and the kidneys are struggling most.”
NF Renal Function Early Care is available in a dry format (1.5kg) and a pouch (tender pieces with chicken 85g).
NF Renal Function Advanced Care is available in 1.5kg and 5kg packs of dry food, and ‘wet’ options of tender pieces with chicken/ salmon (85g pouches) and a mousse (195g can).
Both diets are now available in veterinary wholesalers.
Cystease® S, CEVA Animal Health's urinary tract support product for cats, is now available in a new 100 tablet pack size for greater convenience to the practice.
CEVA`s small animal veterinary advisor Fraser Broadfoot said: "Previously Cystease® S was only available in 300 tablet packs. The new 100 tablet pack size makes the product easier to store in the practice and easier to dispense to clients."
To help vets gain easy access to information on Feline Lower Urinary Tract Disease (FLUTD), CEVA Animal Health have also produced a highly informative technical review on the subject. Produced in conjunction with Professor Danielle Gunn-Moore, head of the feline clinic at the University of Edinburgh, the eight-page, colour brochure contains practical information on the clinical signs, diagnosis and treatment of FLUTD and also includes behavioural advice on reducing stress in cats, which can be a major cause of FLUTD.
To receive a free copy of CEVA's FLUTD technical review and for further information on Cystease® S, please contact Fraser Broadfoot MRCVS on 01494 781510, CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.
330 people who took part in the survey were presented with a list of management and leadership skills. Those of the respondents who are leaders were asked to rate their confidence in applying the skills, whilst those in non-management positions were asked to rate their line manager's skills. Both sets of respondents were also asked to place the skills in priority order.
The management skills were: Setting clear tasks and objectives. Providing clear roles and responsibilities. Communicating clearly and effectively. Monitoring and evaluating. Planning and organising. Effectively managing difficult situations.
The leadership skills were: Providing rationale and explaining why. Regularly providing and seeking feedback. Building trust. Providing guidance and training. Creating development plans and opportunities.
Interestingly, the survey found a close correlation between how the leaders and the employees prioritise these things, with management skills being perceived as more important overall than leadership skills.
Communicating clearly and effectively was deemed the most important skill of all (ranked 9 out of 10 by both groups). Meanwhile, creating development plans and opportunities for others was prioritised the least (ranked 3.7/10).
But hang on a moment. If both the managers and the employees agree that creating development plans and opportunities is the least important thing, then surely it is? In other words, if employees say that creating development plans is unimportant, then surely it is unimportant, and if leaders think the same, they would appear to be right.
Maybe, maybe not. Perhaps employees don't know what's good for them, and leaders don't know what employees don't know what is good for them. If you take my point.
Veterinary leaders were then asked to rate their confidence in applying the listed leadership and management skills. The skills which elicited the largest number of 'not confident' responses were: monitoring and evaluating performance, regularly providing and seeking feedback, and creating development plans and opportunities for others.
The skills with which leaders were most confident were: communicating clearly and effectively, building trust, and providing rationale and explaining why.
Again, there was a close correlation between prioritisation of these skills and confidence levels.
VMG Vice President Richard Casey said: “The survey has helped us to identify priorities for learning and development both at our 2020 Congress and during our joint CPD programme next year. It is striking that the very skills required to motivate colleagues to remain in veterinary medicine and to support them in doing so are the ones which so many veterinary leaders admit that they lack confidence. Given the challenges the profession faces, it is also concerning that they appear to be undervalued both by veterinary leaders and the team members who report to them.
"Delegates to SPVS-VMG Congress and our other 2020 CPD events will benefit from a wealth of evidence-based lectures from experts on all aspects of veterinary leadership and management, enabling them to improve their own performance and contribute to an overall raising of standards of leadership and management across the veterinary sector."
Peter Brown, Senior Vice-President of SPVS, said: "We know that veterinary students receive an excellent clinical training and, in recent years, universities have started to include more non-clinical skills on the curriculum. However, these results suggest that when professionals move into more senior roles, be it leading a team or running their own practice, they find they still need to acquire new skills. SPVS’ role has always been to equip veterinary professionals to be effective leaders and SPVS-VMG congress is an excellent opportunity to both hear inspiring speakers and meet and learn from fellow leaders within the profession."
The VMG-SPVS 2020 joint Congress takes place from 23-25 January at the Celtic Manor Resort, Newport, and will feature dedicated streams on effective leadership, management mastery, practice profitability, preparing for a digital future and sustainability in practice.
Details on the VMG-SPVS 2020 CPD Programme can be found here: https://spvs-vmg-events.co.uk/cpd-events/
Michale Garvey (pictured) has the official title of National Property Coordinator and he will work with local surveyors to ensure that landlords have realistic expectations supported by evidence at rent reviews and lease renewals.
VLA Treasurer Nicky Paull said: "This should help speed up what are sometimes protracted and expensive negotiations to the mutual benefit of corporate tenant and landlord alike.”
Michael is a Chartered Surveyor who has worked in the commercial property sector for 35 years.
He is the Managing Director of Chandler Garvey, a Fellow of both the Royal Institution of Chartered Surveyors and the Chartered Institute of Arbitrators, as well as being an RICS Registered Valuer.
He has specialised in rent reviews and lease renewals all of his career and has been a member of the RICS Arbitrators Panel for more than 10 years.
Michael also has extensive experience of the veterinary sector, having represented owners relating to disputed rent reviews, as well as acquisitions and lettings on different types of premises.
He said: “I am delighted to have been appointed by the VLA as the National Property Coordinator, with the intention of allowing the owners of veterinary premises, to have a better understanding of the rent review and lease renewal processes and in doing so even the playing field so that better outcomes are achieved.
Richard Hillman one of the VLA’s founders said: “Negotiating with large corporate groups can sometimes feel like trying to run through treacle for small landlords.
"Having an acknowledged expert on our team should help the VLA to give much needed support to our members.”
Further information about the VLA can be obtained from Richard Stephenson vicechair@vla.org.uk
https://vla.org.uk
White Cross Vets, a family run group, has been named by The Sunday Times as one of the best places to work in the UK, for the fifth year on the trot.
The company, which operates 16 practices, achieved the highest placing of any veterinary business, reaching 38 in The Sunday Times 'Best 100 Best Small Companies To Work For' league table. It is the first animal health / veterinary business to rank in the prestigious list 5 years running, and it remains the only veterinary practice ever to achieve a three star 'extraordinary' rating in the list’s history.
The Best Companies to Work For survey is now in its 17th year and is designed to rank the cream of Britain’s motivated workforces. It is widely recognised as the most searching and extensive research into employee engagement carried out in the UK.
To achieve the listing in the Best Companies table, all of the White Cross team anonymously answered a series of in-depth questions about everything from personal development opportunities, to workplace wellbeing, contributions in the local community and overall opinions about the business.
Tim Harrison, Managing Director of White Cross Vets, said: "It really has been a case of high fives all round since we found out about this year’s placing, which puts us in this prestigious league table for the fifth consecutive year. We are a family run business that places a huge amount of importance on the wellbeing and happiness of our people and to be recognised for that is incredibly rewarding."
White Cross Vets was also recently awarded with an industry award in recognition of the initiatives it has introduced to ensure its team remain happy, healthy and fulfilled in their work. The company scooped the Society of Practising Veterinary Surgeons’ inaugural Wellbeing Award after the judges scored entrants on everything from development opportunities through to stress reduction initiatives and how they promote wellbeing.
Tim added: "Our employment initiatives include everything from giving everybody a day off and cake for their birthday, right through to providing four donation days a year where people can volunteer with a charity of their choice. We also provide a health care scheme and recently started offering subsidised Fitbits and gym membership as well as running a cycle to work scheme.
"One of our big priorities also involves supporting mental health, and we provide training on this, alongside a 24 hour helpline for emotional and wellbeing support.
"In addition to all of this, each year we run an annual congress packed with Continuing Professional Development (CPD) opportunities and thought-leadership talks on the latest topics affecting our industry. It’s at this event that we also hold an awards ceremony for our 170 strong team, where vets, nurses and client care co-ordinators are singled out for their superb achievements."
Emma, who graduated from the RVC in 2016, first spent five years working for the Poultry Health Services team in North Yorkshire, before moving to Avara to gain on-farm experience as an area manager.
She then rejoined the PHS Sheriff Hutton practice as the veterinary lead for the North East in 2022, opting to return to clinical work where her main interest is in turkeys focusing on gut health.
Emma has a post-graduate diploma in population health, statistics and epidemiology, and sits on both the APHA Avian Expert Group and the British Veterinary Poultry Association committee.
The judges were impressed with Emma's commitment to poultry as well as taking on several other roles on committees supporting the industry.
John Kenyon, Veterinary Manager at award sponsor Zoetis, said: “The poultry industry is looking to attract more vets to specialise in this sector and Emma is a great role model.
“The profession plays an important part in maintaining the high health and welfare standards of the UK industry and the award is a great way to promote career opportunities for young vets.
"Zoetis has sponsored this award since the introduction of the Young Farm Vet category in 2020 and we are proud to see the success past winners have achieved.”
Other finalists included Esme Chapman of Howells Veterinary Services, and Katerina Theakou of Crowshall Veterinary Services.
Does your vet practice or an individual in the team deserve to be recognised for their commitment and dedication to their job? If so, this is your last chance to nominate your practice or colleagues for the Petplan Veterinary Awards held at a glittering award ceremony at BSAVA in April.
You can nominate under four categories:
Alison Andrew, Petplan's Marketing Manager, said: "Nominating your colleagues for an award is a fantastic way of expressing your appreciation for their hard work. The veterinary profession is dedicated to animal welfare and at Petplan we believe that their invaluable care and support deserves special recognition. The 11th annual Petplan Veterinary Awards will bestow great accolades upon the stars of the industry."
Ben Jones was awarded Vet of the Year in 2009. He said: "It was a great honour to be named the 2009 Petplan Vet of the Year and it has had a really positive impact. The award has greatly increased the practice's exposure in the local and national press and we've also been able to use the award to generate our own publicity."
However Ben says the greatest impact of the award has been on his customers: "They were all delighted and I think it gave them a lot of reassurance in the service we provide. It has also generated more business with new clients saying they have come to us because of the award."
Ian Patterson, a partner at St Clair Veterinary Group in Fife, said being named the 2009 Practice of the Year has also had a tremendous impact on their practice. He said: "The award meant so much to everyone right across the practice and the team here is extremely proud of their efforts. It has also given us the opportunity to generate more business through the exposure that the practice has received since winning the award."
You can nominate online at www.petplan.co.uk/vetawards. Remember to also encourage your clients to nominate your team for the contribution you have made to their pets wellbeing.
Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.
Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.
Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future. I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed."
Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org
Dogs Trust, the UK's largest dog welfare charity, has teamed up with leading cardiac rehabilitation experts at Harefield Hospital to help patients in their final phase of coronary recovery.
The recovery programme, Hounds Help Hearts, is, according to the charity, a UK first and encourages post coronary patients to walk dogs as part of their recovery.
The Cardiac Rehabilitation team at Harefield Hospital aims to improve the physical, social and psychological well being of people after a heart attack or similar cardiac event. Among the recommendations for an ongoing healthy lifestyle, patients are being introduced to Dogs Trust Harefield where they can help staff, canine residents and themselves by walking some of the 150 dogs in their care. The charity hopes that heart hospitals UK wide will follow suit.
Hounds Help Hearts is part of a wider initiative to promote The Dog Prescription - a research document that highlights the ways dogs can improve human health. Dogs Trust is urging GPs all over the UK to prescribe a daily dose of dog with The Dog Prescription after research highlights the health benefits of dog ownership for both children and adults.
Lynda Evans, senior nurse /modern matron at Royal Brompton & Harefield NHS Foundation Trust, said: "Walking is one of the best forms of exercise for patients recovering from a cardiac event and what better way to do it than alongside a grateful canine companion. We have been running the 'Care For Your Heart' Rehabilitation Programme for more than 20 years and as a leading specialist heart and lung hospital we are always looking for new ways to help patients to enjoy the best possible quality of life when they return home. We are delighted to be working with Dogs Trust on this initiative and partnering patients with dogs to help them reach their full potential through interaction and physical exercise."
The Dog Prescription highlights the mental and physical benefits of dog ownership and interaction and names dog ownership as an aid to the recovery of post coronary patients
Clarissa Baldwin, Dogs Trust CEO said: "We undertook this research as we were aware of the health benefits of dog ownership but wanted to fully evaluate its potential. Amongst its ten points (which are not exhaustive), the prescription details health benefits including the fact that dogs can aid the recovery of post coronary patients. We want to spread the word about the health benefits of dogs and we hope that GPs and hospitals will start to encourage patients to engage with dogs for a healthier and happier lifestyle"
You can read the full research here.
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
The British Equine Veterinary Association (BEVA) has released the results of a survey carried out earlier this year which has found that there may be up to 5 times as many veterinary graduates wanting to work in equine practice as there are jobs available.
The survey was carried out amongst the 2,500 vets and vet students who are members of BEVA to help ascertain manpower requirements of equine practices in the UK.
Of the 819 new veterinary graduates in the UK in 2012, BEVA says it estimates conservatively that between 10-15% intend to work in equine practice. Meanwhile, the extrapolated results of the survey suggest that in 2012 there was less than 1% growth in full time equine vet positions and as few as 24 new permanent jobs available in the UK.
BEVA says that in line with the survey's suggestion of restricted opportunities, some of its members are also finding that internships, commonly the domain of new graduates to gain paid, supervised experience in practice, are now often taken by vets with some post-graduate experience. Furthermore, unpaid externships, which traditionally gave vet students valuable work experience, appear to be being filled by unemployed veterinary graduates wanting to gain experience in order to improve their chances of securing a job in equine practice.
Tim Mair, a partner at Bell Equine Veterinary Clinic in Kent said: "Earlier this year we had more than 80 applications for just one internship. Several years ago we would expect 50 or so applications for an advertised intern post but now, without advertising at all, we are constantly receiving applications, not just from new graduates but also from those who have been qualified for a year or more."
Charlie Schreiber, a partner at Donnington Grove Veterinary Surgery in Berkshire, said: "We take on an average of two externs a month and over the past four years have had more than 350 applicants but their calibre is noticeably changing. We used to hear primarily from students but now it tends to be recent graduates or those who have already done a job in mixed practice and are keen to move into equine but can't find an internship."
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, said: "In addition to the numerous applications we received for our recently advertised internship position, we are inundated with unsolicited enquiries about job opportunities from recent veterinary graduates from across the globe. Our most recent advertisement for an equine veterinary nurse has attracted interest from a handful of recently qualified vets desperate to find work. This employment problem is not confined to internships; some of our recent interns have found it very difficult, if not impossible to find a job in horse practice, once they've completed their internship."
Amanda Piggot, a recent graduate, has first hand experience of the challenge of finding a suitable placement. She said: "I have always wanted to work in equine practice and my approach has been very strategic. It took me five months to find my current position at Kessock Equine Vets in Inverness, which necessitated moving 500 miles further north than I ideally wanted. For my next position I applied to Liphook twice and had no luck but I have now been accepted by Rossdales for a two year internship."
According to the British Veterinary Association (BVA) the problem isn't confined to equine practice. The Association's President Peter Jones said: "The findings of the BEVA survey make sober reading and reflect the growing concerns in the wider veterinary profession about opportunities for new graduates in all types of veterinary practice.
"The issue has recently been brought into sharp focus by the announcement of a new veterinary school opening at the University of Surrey in 2014, with many BVA and BEVA members worried about an oversupply of veterinary graduates into an already competitive market. We are expecting the results of the RCVS survey of recent graduates shortly and, alongside the findings of the BEVA survey, they will provide an evidence-base to build on as we continue to assess the UK veterinary manpower implications of potential new veterinary schools in the future."
BEVA is keen to help both potential employees and employers tackle the situation as constructively as possible. BEVA President Keith Chandler said: "BEVA is proud that equine practice is attractive to so many younger members of the profession and it can provide a rewarding and fulfilling career. However we urge all stakeholders to ensure that current and prospective veterinary students are fully aware of the very limited opportunities in equine practice. Most of all we urge the students themselves to consider carefully their career path and prospects before making their final decisions."
Next month the RCVS will be releasing details of a survey of vets who have graduated within the past five years and how easy they have found it to find a job that meets their needs.
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.
Dechra Veterinary Products (maker of Cardisure) has launched a new online CPD course which consists of a series of short presentations about treating congestive heart failure in dogs, developed with cardiology consultant Mike Martin.
According to the company, approximately 10% of dogs presented to first opinion practices have heart disease. The majority of cases are suffering with myxomatous mitral valve disease (MMVD) or, less commonly, dilated cardiomyopathy (DCM).
Mike said: "This is a series of short presentations with audio, that covers the common challenges, issues and questions that we all encounter in clinical practice. Aimed squarely at the very busy practitioner, this 'piece by piece' course will help you differentiate between cardiac and respiratory cases, update you on the current ACVIM guidelines on the treatment of heart failure in dogs and how best to monitor your patient in the short to long term. It's been a fun series to put together with the help of Dechra – enjoy."
Craig Sankey, Business Manager for Cardiology at Dechra said: "This series of bite-sized videos highlight the importance of diagnosing, treating and monitoring congestive heart failure in dogs in an interactive e-learning environment, topped with quizzes and drag and drops to test ones knowledge.
"Furthermore, the beauty of this format means Veterinary Professionals can dip in and out of each section depending on the area they need to build their expertise, without the pressure of completing the whole course all at once’.
The course equates to one hour CPD and can be found on the Dechra Academy: https://academy.dechra.com/learn/course/external/view/elearning/718/cardiology-piece-by-piece
More information about Cardisure can be found at www.dechra.co.uk/Cardisure
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.